Reaction
Proteus Infection reporting signals
As of the last recalculation, Proteus Infection appears in 713 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 82.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 33 | 82.8 | 83.0 |
| Valganciclovir | 34 | 55.2 | 55.3 |
| Valganciclovir Hydrochloride | 34 | 55.2 | 55.3 |
| Atovaquone | 13 | 48.0 | 48.1 |
| Anti-Thymocyte Globulin (Rabbit) | 13 | 47.9 | 48.0 |
| Trimethoprim | 16 | 40.5 | 40.6 |
| Tacrolimus Ointment 0.1% | 93 | 24.9 | 24.9 |
| Tacrolimus Extended-Release Capsules | 93 | 24.9 | 24.9 |
| Micafungin Sodium | 7 | 24.3 | 24.4 |
| Aflibercept | 25 | 24.2 | 24.2 |
| Ganciclovir | 8 | 23.1 | 23.1 |
| Ganciclovir Sodium | 8 | 22.3 | 22.3 |
| Amphotericin B | 9 | 21.2 | 21.2 |
| Polatuzumab Vedotin | 7 | 21.1 | 21.2 |
| Amikacin | 12 | 20.9 | 20.9 |
| Tacrolimus | 96 | 20.5 | 20.5 |
| Cetuximab | 19 | 18.2 | 18.2 |
| Ixazomib | 10 | 10.3 | 10.3 |
| Azacitidine For | 6 | 9.7 | 9.7 |
| Pomalidomide | 17 | 4.9 | 4.9 |